Iksuda Therapeutics

Biotechnology ResearchTyne and Wear, United Kingdom11-50 Employees

Through our highly experienced ADC Research & Development Team, we are building a pipeline of class-leading ADCs with superior therapeutic index (TI) for difficult-to-treat cancers.

Our approach is to develop the best ADC for any given target or tumor sub-type rather than 'technology-driven ADCs'. 

All our ADCs incorporate tumor-selective release & activation of the most relevant payload according to mechanism, optimizing anti-cancer efficacy and enhancing patient safety.

Sign up for free to view info

Email Format Employee directory